Clinical study of the use of Bevacizumab in glaucoma surgery.
- Conditions
- Primary Open Angle Glaucoma (POAG) patients.
- Registration Number
- RBR-9wkw73j
- Lead Sponsor
- nião Metropolitana de Educação e Cultura
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
The inclusion criteria will be: Primary Open Angle patients over 40 years of age, with uncontrolled Intraocular pressure (IOP) on maximum tolerated medical therapy, requiring trabeculectomy. Indications for trabeculectomy will include eyes where IOP measurements associated with a high probability of glaucoma progression or eyes where a deterioration of the visual field or the optic disk compatible with progressive glaucomatous damage was documented by the examining physician.
Patients will be excluded if known to have an allergic reaction either to MMC or BZM, had undergone previous intraocular surgery (except uneventful cataract surgery); were diagnosed with normal tension glaucoma, angle closure glaucoma or secondary glaucomas; had prior history of ocular infection, uveitis or ocular trauma; were pregnant or breast-feeding women; had a history of uncontrolled diabetes and/or systemic hypertension or any other systemic condition that could be influenced by BZM injections
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method